000 | 01463 a2200385 4500 | ||
---|---|---|---|
005 | 20250511212301.0 | ||
264 | 0 | _c19910823 | |
008 | 199108s 0 0 eng d | ||
022 | _a0305-7453 | ||
024 | 7 |
_a10.1093/jac/27.suppl_c.1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuscato, J J | |
245 | 0 | 0 |
_aAn evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage. _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _cMay 1991 |
||
300 |
_a1-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcinetobacter _xdrug effects |
650 | 0 | 4 |
_aAmikacin _xadministration & dosage |
650 | 0 | 4 | _aCancer Care Facilities |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aDrug Utilization |
650 | 0 | 4 |
_aEnterobacteriaceae _xdrug effects |
650 | 0 | 4 |
_aGentamicins _xadministration & dosage |
650 | 0 | 4 |
_aGram-Negative Bacteria _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
650 | 0 | 4 | _aR Factors |
650 | 0 | 4 |
_aTobramycin _xadministration & dosage |
700 | 1 | _aWilbur, D W | |
700 | 1 | _aStout, J J | |
700 | 1 | _aFahrlender, R A | |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 27 Suppl C _gp. 1-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/27.suppl_c.1 _zAvailable from publisher's website |
999 |
_c1913058 _d1913058 |